Guardant Health
GH
#2639
Rank
S$6.78 B
Marketcap
$54.97
Share price
1.35%
Change (1 day)
117.22%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Net assets

Net assets on the balance sheet as of December 2024 : -S$0.19 Billion

According to Guardant Health 's latest financial reports the company has -S$0.19 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Guardant Health - Net assets on balance sheet (from 2017 to 2024)

Net assets by year

Year Net assets Change
2024-12-31$-S$0.19 Billion-190.57%
2023-12-31$S$0.20 B159.77%
2022-12-31$S$80.67 M-90.75%
2021-12-31$S$0.87 B-51.38%
2020-12-31$S$1.79 B56.87%
2019-12-31$S$1.14 B59.41%
2018-12-31$S$0.71 B73.75%
2017-12-31$S$0.41 B257.85%
2016-12-31$S$0.11 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
S$1.59 B-956.03%๐Ÿ‡บ๐Ÿ‡ธ USA
S$3.56 B-2,011.30%๐Ÿ‡บ๐Ÿ‡ธ USA